Brainomix has developed Brainomix 360 Stroke, an AI-powered platform that analyses medical images to support stroke diagnosis and treatment.

Brainomix, a company pioneering AI-powered imaging tools in stroke and lung fibrosis, today announced the completion of a ...

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...

Brainomix entered the US market in 2023 having gained several FDA clearances for modules within its stroke care platform.

Boehringer Ingelheim says it is on track to ... fuelled by an R&D pipeline that it says is the best in its 139-year history. The company expects to start around 10 new phase 2 and 3 trials within ...

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

Black History Month may have passed, but a local museum is continuing to pay homage to historical movements with some new exhibits. The Museums, 3406 Frederick Ave., is working on an interactive Civil ...

Tempus AI's financials have significantly improved, with positive cash flow expected next quarter. Read why TEM stock is a ...

Fan Zhang, PhD, of the University of Colorado Department of Medicine sees artificial intelligence as a pathway to combating an intractable enemy: rheumatoid arthritis.

The National Kidney Foundation (NKF) is proud to announce that its KidneyCARE (Community Access to Research Equity)tm Study ? the first national CKD patient registry that captures both ...

People with intermediate-risk scores on coronary artery calcium testing who received statins and intensive health coaching ...